Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID‐19

OBJECTIVES: Coronavirus disease 2019 (COVID‐19) is rapidly spreading worldwide. Lianhua Qingwen capsule (LQC) has shown therapeutic effects in patients with COVID‐19. This study is aimed to discover its molecular mechanism and provide potential drug targets. MATERIALS AND METHODS: An LQC target and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cell Prolif
Main Authors: Xia, Qi‐Dong, Xun, Yang, Lu, Jun‐Lin, Lu, Yu‐Chao, Yang, Yuan‐Yuan, Zhou, Peng, Hu, Jia, Li, Cong, Wang, Shao‐Gang
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Original Manuscripts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7705900/
https://ncbi.nlm.nih.gov/pubmed/33140889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12949
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki